PRF1 and leukemia: Our findings demonstrate that CD8+ T cells from Cat-Tg mice have enhanced activation markers, significantly altered CD8+ T cells phenotype, enhanced expression of Granzyme B and Perforin, and exert better cytotoxicity against primary leukemia cells than CD8+ T cells from WT mice.